•  Selects and prioritises promising drug candidates
•  Prioritises derivatives even of different lead structures
•  Simple usage and integration of results
•  Reduces clinical failures

MolScore-Drugs can be used to detect promising drug candidates in multiple therapeutic areas, including:

• CNS-diseases
• infectious diseases
• cardiovascular
  diseases
• respiratory diseases
• renal diseases
• but is not limited to these diseases.

The examination of more than 500.000 commercial available compounds used for HTS showed that only a low amount of these compounds will satisfy the requirements of becoming a promising drug.

Application & Advantages

MolScore-Drugs prioritises drugs in multiple therapeutic areas correctly. Below are some prediction results of MolScore-Drugs on drugs, which are or have been on the market.

MolScore-Drugs
measures the probability
of a compound
to become a successful drug
 and is defined as a value between
0 and 1.
 

Expert system
to estimate
oral bioavailability
 in humans.

The expert system identifies general molecular patterns and properties of save and successful drugs.